Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|April 7, 2011
Supplements and Featured Publications
- Managing the Hepatitis C Virus: Challenges and Opportunities for Managed Care [CME/CPE]
- Volume 17
- Issue 4 Suppl
Managing the Hepatitis C Virus: Challenges and Opportunities for Managed Care
Advertisement
Instructions
After reading “Managing the Hepatitis C Virus: Challenges and Opportunities for Managed Care,” complete the program evaluation and select the 1 best answer to each of the posttest questions.
A statement of continuing education hours will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher.
Articles in this issue
over 15 years ago
Emerging Therapeutic Options in Hepatitis C Virus Infectionover 15 years ago
Diagnosing and Treating Hepatitis C Virus Infectionover 15 years ago
Participating Faculty: Manging the Hepatitis C VirusAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
New York Experts Push for Coordinated Obesity Care Teams
4
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
5